Join to access to all OVN content. Join for Free
Illuminating science for patients and healthcare professionals through plain language podcasts
patient engagement in podcasts medical education podcasts MedComms webinars scientific communication for patients expert-led

Illuminating science for patients and healthcare professionals through plain language podcasts


Share This Article


Summary

Note this is a video recording of an online meeting conducted using the Zoom.us platform. Inevitably such recordings suffer a little in terms of their production values because of the internet connectivity and quality of webcams. Despite that, they allow us to provide additional valuable insights in to the MedComms business and we can involve a wider range of speakers who can participate from the comfort of their own desks, wherever in the world they are.

Expert-led podcasts summarising the latest clinical data and expert opinion, including discussions of data presented at scientific congresses, have been published by journals as peer-reviewed, citable publications. They have also been published as part of IME (independent medical education) programmes. But is it possible to create these podcasts in plain language, with both patient and healthcare professional authors? If we are trying to educate a broad audience of stakeholders (from lay audiences to highly specialised clinicians) with scientific content, can patients be podcast authors and create content with maximum impact? The answer to these key questions is yes!

Join Caroline Halford from Springer Healthcare, Niamh Clarke from Adis, and Catherine Elliott and Simon Stones from Envision Pharma Group to hear about their experience of creating plain language podcasts and the potential for using these types of initiative to make scientific information more impactful, and more accessible to a wider audience.

And we answer questions from the audience.

It should be of interest to anyone who is working in and around MedComms, publications, medical education, or has an interest in patient engagement.

Recorded 09 November 2022 as a MedComms Networking webinar. Produced by NetworkPharma.tv

Find out more about Springer Healthcare and Adis journals at https://springerhealthcare.com/

Find out more about Envision Pharma Group at https://www.envisionpharmagroup.com/

Further information:

Patient and Healthcare Professional Perspectives from ESMO 2021 on Bladder and Kidney Cancer: A Podcast
See https://link.springer.com/article/10.1007/s40487-022-00185-5

CME patient podcasts from Springer Healthcare IME,
See https://fop.ime.springerhealthcare.com/insights/#podcasts

Click for Source
patient engagement in podcasts, medical education podcasts, MedComms webinars, scientific communication for patients, expert-led

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Article
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Partner Avatar iNIZIO

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Explore OVN